Elena Tsitsami

1.1k total citations
17 papers, 249 citations indexed

About

Elena Tsitsami is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Elena Tsitsami has authored 17 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 9 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Elena Tsitsami's work include Autoimmune and Inflammatory Disorders Research (9 papers), Inflammasome and immune disorders (7 papers) and Kawasaki Disease and Coronary Complications (3 papers). Elena Tsitsami is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (9 papers), Inflammasome and immune disorders (7 papers) and Kawasaki Disease and Coronary Complications (3 papers). Elena Tsitsami collaborates with scholars based in Greece, Italy and United Kingdom. Elena Tsitsami's co-authors include Polyxeni Pratsidou‐Gertsi, Maria Trachana, F Kanakoudi-Tsakalidou, Matthaios Speletas, Anastasios E. Germenis, Nicolino Ruperto, Katerina Laskari, Petros P. Sfikakis, Loukas Settas and Dimitrios Pikazis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Elena Tsitsami

15 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Tsitsami Greece 8 116 113 98 63 36 17 249
Alyette Duquesne France 7 135 1.2× 66 0.6× 74 0.8× 29 0.5× 45 1.3× 7 244
Julia García-Consuegra Spain 6 156 1.3× 61 0.5× 84 0.9× 84 1.3× 34 0.9× 7 315
Robert J. Postlethwaite United Kingdom 8 42 0.4× 86 0.8× 62 0.6× 23 0.4× 45 1.3× 15 306
Inmaculada Calvo Penadés Spain 7 44 0.4× 37 0.3× 85 0.9× 61 1.0× 37 1.0× 23 208
Emilia Escuredo United Kingdom 5 101 0.9× 33 0.3× 49 0.5× 50 0.8× 28 0.8× 9 400
Nancy A. Bishof United States 8 48 0.4× 88 0.8× 46 0.5× 43 0.7× 37 1.0× 9 334
Annette von Scheven-Gête Switzerland 8 196 1.7× 125 1.1× 88 0.9× 30 0.5× 49 1.4× 11 306
El-Monsor Shobowale–Bakre United Kingdom 7 63 0.5× 26 0.2× 63 0.6× 53 0.8× 30 0.8× 10 444
Koyo Yoshida Japan 9 26 0.2× 55 0.5× 28 0.3× 50 0.8× 49 1.4× 37 332
Loïk Geffray France 5 21 0.2× 48 0.4× 81 0.8× 117 1.9× 44 1.2× 9 227

Countries citing papers authored by Elena Tsitsami

Since Specialization
Citations

This map shows the geographic impact of Elena Tsitsami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Tsitsami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Tsitsami more than expected).

Fields of papers citing papers by Elena Tsitsami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Tsitsami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Tsitsami. The network helps show where Elena Tsitsami may publish in the future.

Co-authorship network of co-authors of Elena Tsitsami

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Tsitsami. A scholar is included among the top collaborators of Elena Tsitsami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Tsitsami. Elena Tsitsami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tsitsami, Elena, et al.. (2023). Natural autoimmunity in oligoarticular juvenile idiopathic arthritis. Pediatric Rheumatology. 21(1). 44–44. 3 indexed citations
2.
Καραμανάκος, Αναστάσιος, Maria G. Tektonidou, Olga Vougiouka, et al.. (2022). Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosage. Seminars in Arthritis and Rheumatism. 56. 152055–152055. 5 indexed citations
3.
Rosina, Silvia, Giulia Varnier, Angela Pistorio, et al.. (2020). Development and Testing of Reduced Versions of the Manual Muscle Test-8 in Juvenile Dermatomyositis. The Journal of Rheumatology. 48(6). 898–906. 4 indexed citations
4.
Özen, Seza, Erdal Sağ, Eldad Ben‐Chetrit, et al.. (2020). Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach. Lara D. Veeken. 60(8). 3799–3808. 42 indexed citations
5.
Pratsidou‐Gertsi, Polyxeni, Maria Trachana, F Kanakoudi-Tsakalidou, et al.. (2018). The Greek version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatology International. 38(S1). 219–226. 2 indexed citations
6.
Tsitsami, Elena, et al.. (2017). SIAE Rare Variants in Juvenile Idiopathic Arthritis and Primary Antibody Deficiencies. Journal of Immunology Research. 2017. 1–11. 4 indexed citations
7.
Laskari, Katerina, Panagiota Boura, George N. Dalekos, et al.. (2016). Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever. The Journal of Rheumatology. 44(1). 102–109. 42 indexed citations
8.
Laskari, Katerina, Panagiota Boura, Alexandros Garyfallos, et al.. (2016). FRI0497 The Interleukin-1 Inhibitor Canakinumab for Familial Mediterranean Fever: Long-Term Beneficial Effect in A Cohort of 14 Patients. Annals of the Rheumatic Diseases. 75. 618–619. 1 indexed citations
9.
Speletas, Matthaios, Antonios Gounaris, Maria Kompoti, et al.. (2015). MBL2Genotypes and Their Associations with MBL Levels and NICU Morbidity in a Cohort of Greek Neonates. Journal of Immunology Research. 2015. 1–10. 12 indexed citations
11.
Tsitsami, Elena, et al.. (2014). Indications and efficacy of canakinumab in Familial Mediterranean Fever: report of three cases. Pediatric Rheumatology. 12(S1).
12.
Tsitsami, Elena, et al.. (2013). A Case of Hyperimmunoglobulinemia D Syndrome Successfully Treated with Canakinumab. SHILAP Revista de lepidopterología. 2013. 1–4. 11 indexed citations
13.
Speletas, Matthaios, et al.. (2009). Hereditary angioedema in Greek families caused by novel and recurrent mutations. Human Immunology. 70(11). 925–929. 11 indexed citations
14.
Magni‐Manzoni, Silvia, Elena Tsitsami, C Gasparini, et al.. (2005). Responsiveness of clinical measures to flare of disease activity in juvenile idiopathic arthritis.. PubMed. 23(3). 421–5. 19 indexed citations
15.
Tsitsami, Elena, Elena Bozzola, Silvia Magni‐Manzoni, et al.. (2003). Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis. Arthritis Care & Research. 49(4). 488–493. 17 indexed citations
16.
Pratsidou‐Gertsi, Polyxeni, Olga Vougiouka, Elena Tsitsami, et al.. (2002). The Greek version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ).. PubMed. 19(4 Suppl 23). S76–80. 7 indexed citations
17.
Kanakoudi-Tsakalidou, F, et al.. (2002). Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy.. PubMed. 19(5). 589–94. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026